Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Drug Combination for Alcohol-Use Disorders: A Human Laboratory Study

NCT03575403 is registered in ClinicalTrials.gov with Craig Rush as lead sponsor.

NCT NCT03575403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03575403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Drug Combination for Alcohol-Use Disorders: A Human Laboratory Study
Lead sponsor
Craig Rush
Phase
Phase 1
Overall status
Completed
Start date
September 1, 2018
Completion date
March 15, 2023
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder